Search research articles
Contact Us
Filters
Showing results (691-700 of 723) with videos related to
Page
of 73
Sort By:
Health Technology Assessment (Winchester, England)
|
May 9, 2026
Clinical and cost-effectiveness of negative pressure wound therapy versus usual care for surgical wounds healing by secondary intention: the SWHSI 2 pragmatic RCT
Catherine Arundel, Laura Mandefield, Caroline Fairhurst, et al.
JCO Precision Oncology
|
March 30, 2026
Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced <i>ALK</i>-Rearranged Squamous and Adenosquamous Non-Small Cell Lung Cancers
Emily A Miao, Beow Yeap, Sameh Daher, et al.
Elife
|
March 28, 2023
Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial
Astha Thakkar, Kith Pradhan, Benjamin Duva, et al.
The Journal of Clinical Investigation
|
March 23, 2023
Durability of immune responses to mRNA booster vaccination against COVID-19
Prabhu S Arunachalam, Lilin Lai, Hady Samaha, et al.
Cancer Causes & Control : CCC
|
May 25, 2024
LGBTQ+ cancer: priority or lip service? A qualitative content analysis of LGBTQ+ considerations in U.S. state, jurisdiction, and tribal comprehensive cancer control plans
Austin R Waters, Madeline H Bono, Mayuko Ito Fukunaga, et al.
Nature Aging
|
October 14, 2025
Cerebrospinal fluid proteomic signatures in cognitively normal individuals identify distinct clusters linked to neurodegeneration
Dahun Seo, Anh N Do, Gyujin Heo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2024
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT
Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz, et al.
Clinical Lung Cancer
|
February 11, 2025
CNS Outcomes of Osimertinib Plus Chemotherapy in Patients With EGFR Mutation Positive Lung Cancer Beyond Osimertinib Progression
Wesley K Y Wong, Kevin K S Mok, Giselle P C Tsui, et al.
Biorxiv : the Preprint Server for Biology
|
March 18, 2026
Mesoscale molecular architecture of the human striatum across cell types and lifespan
Andrew W Kraft, Matthew Lee, Nirmala Rayan, et al.
JCI Insight
|
November 3, 2018
Transcriptomic heterogeneity in multifocal prostate cancer
Simpa S Salami, Daniel H Hovelson, Jeremy B Kaplan, et al.
Page
of 73
Search research articles
Search
Showing results (691-700 of 723) with videos related to
Sort By:
Page
of 73
Health Technology Assessment (Winchester, England)
|
May 9, 2026
Clinical and cost-effectiveness of negative pressure wound therapy versus usual care for surgical wounds healing by secondary intention: the SWHSI 2 pragmatic RCT
Catherine Arundel, Laura Mandefield, Caroline Fairhurst, et al.
JCO Precision Oncology
|
March 30, 2026
Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced <i>ALK</i>-Rearranged Squamous and Adenosquamous Non-Small Cell Lung Cancers
Emily A Miao, Beow Yeap, Sameh Daher, et al.
Elife
|
March 28, 2023
Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial
Astha Thakkar, Kith Pradhan, Benjamin Duva, et al.
The Journal of Clinical Investigation
|
March 23, 2023
Durability of immune responses to mRNA booster vaccination against COVID-19
Prabhu S Arunachalam, Lilin Lai, Hady Samaha, et al.
Cancer Causes & Control : CCC
|
May 25, 2024
LGBTQ+ cancer: priority or lip service? A qualitative content analysis of LGBTQ+ considerations in U.S. state, jurisdiction, and tribal comprehensive cancer control plans
Austin R Waters, Madeline H Bono, Mayuko Ito Fukunaga, et al.
Nature Aging
|
October 14, 2025
Cerebrospinal fluid proteomic signatures in cognitively normal individuals identify distinct clusters linked to neurodegeneration
Dahun Seo, Anh N Do, Gyujin Heo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2024
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT
Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz, et al.
Clinical Lung Cancer
|
February 11, 2025
CNS Outcomes of Osimertinib Plus Chemotherapy in Patients With EGFR Mutation Positive Lung Cancer Beyond Osimertinib Progression
Wesley K Y Wong, Kevin K S Mok, Giselle P C Tsui, et al.
Biorxiv : the Preprint Server for Biology
|
March 18, 2026
Mesoscale molecular architecture of the human striatum across cell types and lifespan
Andrew W Kraft, Matthew Lee, Nirmala Rayan, et al.
JCI Insight
|
November 3, 2018
Transcriptomic heterogeneity in multifocal prostate cancer
Simpa S Salami, Daniel H Hovelson, Jeremy B Kaplan, et al.
Page
of 73